90 related articles for article (PubMed ID: 18470916)
41. Epstein-Barr virus in Hodgkin's disease patients in Japan.
Tomita Y; Ohsawa M; Kanno H; Hashimoto M; Ohnishi A; Nakanishi H; Aozasa K
Cancer; 1996 Jan; 77(1):186-92. PubMed ID: 8630928
[TBL] [Abstract][Full Text] [Related]
42. Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study.
Solans M; Serra L; Renart G; Osca-Gelis G; Comas R; Vilardell L; Gallardo D; Marcos-Gragera R
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S164-S169. PubMed ID: 28590273
[TBL] [Abstract][Full Text] [Related]
43. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.
Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundström C; Adami HO; Glimelius B; Melbye M
Cancer Res; 2007 Mar; 67(5):2382-8. PubMed ID: 17332371
[TBL] [Abstract][Full Text] [Related]
44. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
[TBL] [Abstract][Full Text] [Related]
45. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease.
Sergentanis TN; Kanavidis P; Michelakos T; Petridou ET
Eur J Cancer Prev; 2013 Mar; 22(2):131-50. PubMed ID: 22759975
[TBL] [Abstract][Full Text] [Related]
46. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
48. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
49. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.
Yaqo RT; Hughson MD; Sulayvani FK; Al-Allawi NA
Indian J Cancer; 2011; 48(4):446-51. PubMed ID: 22293258
[TBL] [Abstract][Full Text] [Related]
50. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
51. The association between socioeconomic status and survival among children with Hodgkin and non-Hodgkin lymphomas in a universal health care system.
Darmawikarta D; Pole JD; Gupta S; Nathan PC; Greenberg M
Pediatr Blood Cancer; 2013 Jul; 60(7):1171-7. PubMed ID: 23129171
[TBL] [Abstract][Full Text] [Related]
52. Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude.
Borchmann S; Müller H; Engert A
Sci Rep; 2017 Nov; 7(1):14903. PubMed ID: 29097683
[TBL] [Abstract][Full Text] [Related]
53. Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
Weibull CE; Björkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Int J Cancer; 2019 Sep; 145(5):1200-1208. PubMed ID: 30666628
[TBL] [Abstract][Full Text] [Related]
54. [Hodgkin lymphoma in Italian children and adolescents].
Dal Maso L; Terracini B; Mosso ML; Buzzoni C;
Epidemiol Prev; 2016; 40(5):382. PubMed ID: 27764936
[No Abstract] [Full Text] [Related]
55. Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040.
Singh D; Vaccarella S; Gini A; De Paula Silva N; Steliarova-Foucher E; Bray F
Int J Cancer; 2022 Jun; 150(12):1941-1947. PubMed ID: 35080783
[TBL] [Abstract][Full Text] [Related]
56. Current considerations in AYA Hodgkin lymphoma.
Crombie JL; LaCasce AS
Br J Haematol; 2019 Jan; 184(1):72-81. PubMed ID: 30460695
[TBL] [Abstract][Full Text] [Related]
57. Clinical, molecular, and environmental risk factors for hodgkin lymphoma.
Maggioncalda A; Malik N; Shenoy P; Smith M; Sinha R; Flowers CR
Adv Hematol; 2011; 2011():736261. PubMed ID: 21127715
[TBL] [Abstract][Full Text] [Related]
58. Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.
Salati M; Cesaretti M; Macchia M; Mistiri ME; Federico M
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014048. PubMed ID: 25045456
[TBL] [Abstract][Full Text] [Related]
59. Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia.
Arakelyan J; Movsisyan A; Sargsyan L; Chopikyan A; Andreasyan D; Torosyan A; Papyan R; Vardevanyan H; Bardakhchyan S; Tadevosyan A; Tamamyan G; Tananyan A; Danielyan S; Kazandjian D
Ecancermedicalscience; 2021; 15():1319. PubMed ID: 35047070
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
